Fundamental
40.8%
Upside to analyst mean target
of 15.8x and of 0.87 suggest undervaluation relative to past growth, but with Q2 miss and Q3 guidance below consensus, earnings estimates are likely to be revised down, making the forward multiple potentially less attractive. 13.8x is moderate. The stock appears cheap on a trailing basis, but the cash flow crunch and capex intensity justify a discount. Valuation will remain under pressure until visibility on AI returns improves.